Early, complete infart vessel patency: Arriving at a gold standard for future clinical investigation in myocardial reperfusion

Journal of Thrombosis and Thrombolysis

Volumn 4, Issue 2, 1997, Pages 259-266

  Johnson, Todd L ^a   Topol, Eric J ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Cardiology ^*  (United States)

Author keywords

Coronary; Myocardium; Patency; Reperfusion

Indexed keywords

ANISTREPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE HEART INFARCTION; ANGIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; FIBRINOLYTIC THERAPY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RECANALIZATION; REVIEW; RISK; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

EID: 0030951824     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008899002382     Document Type: Review

References (76)

1. Blumgart HL, Gilligan R, Schlesinger MJ. Experimental studies on the effect of temporary occlusion of coronary arteries. II. The production of myocardial infarction. Am Heart J 1941;22:374-389.
2. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death, II: Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40: 633-644.
3. De Wood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
4. White HD, Norris RM, Brown MA, Brandt WT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
5. Cerqueiria MD, Maynard C, Ritchie JL, Davis KB, Kennedy JW. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials. J Am Coll Cardiol 1992;20:1452-1459.
6. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardico (GISSI). Effectiveness of intrevenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:871-874.
7. The ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). N Engl J Med 1986;314:1465-1471.
8. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2:349-360.
9. Topol EJ, Califf RM, George BS, et al. and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317: 581-588.
10. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis In Myocardial Infarction (TIMI) trial, Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-154.
11. Dalen JE, Gore JM, Braunwald E, et al. and the TIMI Investigators. Six- and twelve-month follow-up of the Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial. Am J Cardiol 1988;62:179-185.
12. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: Should the paradigm be expanded? Circulation 1989;79:441-444.
13. White HD, Rivers JT, Maslowski AH, et al. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N Engl J Med 1989;320:817-821.
14. Gruppo Italiano per lo Studio della Soprevuivenza nell'Infarcto Miocardico. GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-70.
15. ISIS-3 (Third International Study of Infarct Survival). A randomised comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-770.
16. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983;309: 1477-1482.
17. Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981;63:307-317.
18. Golino P, Ashton JH, Glas-Greenwalt P, McNutt J, Buja LM, Willerson JT. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. Circulation 1988;77:678-684.
19. Eidt JF, Allison P, Noble S, et al. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 1992; 84:18-27.
20. Grines CL, Topol EJ, Bates ER, Juni JE, Walton JA, O'Neill WW. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: Prediction of clinical outcome. Am. Heart J 1988;115:1-7.
21. Davies GJ, Chierchia S, Maseri A. Prevention of myocardial infarction by very early treatment with intracoronary streptokinase: Some clinical observations. N Engl J Med 1984;311:1488-1492.
22. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987;317:1055-1059.
23. Schaer DH, Ross AM, Wasserman AG. Reinfarction, recurrent angina, and re-occlusion after thrombolytic therapy. Circulation 1987;72:II57-II62.
24. Ohman EM, Califf RM, Topol EJ, et al. and the TAMI Study Group. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990;82:781-791.
25. Kennedy JW, Ritchie JL, Davis KB, Stadius ML, Maynard C, Fritz JK. The Western Washington Randomized Trial of intracoronary streptokinase in acute myocardial infarction: A 12-month follow-up report. N Engl J Med 1985;312: 1073-1078.
26. The TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985;312:932-936.
27. Flygenring BP, Sheehan FH, Iennedy JW, et al. for the TIMI Investigators. Does arterial patency 90 minutes following thrombolytic therapy predict 42 day survival? (abstr). J Am Coll Cardiol 1991;17:275A.
28. Karagounis L, Sorensen SG, Menlove RL, Morena F, Anderson JL, for the TEAM-2 Investigators. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. J Am Coll Cardiol 1992;19:1-10.
29. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early reperfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993;21:1391-1395.
30. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL, for the TEAM-3 Investigators. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Circulation 1993;87:1829-1839.
31. Simes RJ, Topol EJ, Holmes DR, et al. for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation 1995;91:1923-1928.
32. Hackworthy RA, Sorensen SG, Fitzpatrick PG, et al. for the APSAC Investigators. Dependence of assessment of coronary artery reperfusion during acute myocardial infarction on angiographic criteria and interobserver variability. Am J Cardiol 1988;62:538-542.
33. Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;88:1361-1374.
34. Leung WH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol 1992;20:307-313.
35. Grines CL, Browne KF, Marco J, et al. for the Primary Angioplasty in Myocardial Infarction Study Group. A com-parison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1963;328: 685-691.
36. Krug A, Du Mesnil de Rochemont W, Korb G. Blood supply to the myocardium after temporary coronary occlusion. Circ Res 1966;19:57-62.
37. Kloner RA, Ganote CE, Jennings RB. The no reflow phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-1508.
38. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation 1980;62: 945-952.
39. Feld H, Lichstein E, Schachter J, Shani J. Early and late angiographic findings of the "no-reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. Am Heart J 1992;123:782-784.
40. Komamura K, Kitakaze M, Nishida K, et al. Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: Clinical documentation of the no reflow phenomenon after successful thrombolysis. J Am Coll Cardiol 1994;24:370-377.
41. Serruys PW, DiMario C, Kern MJ. Intracoronary Doppler. Philadelphia: WB Saunders, 1994:1069-1121.
42. Kern MJ, Donohue TJ, Bach RG, Aguirre FU, Caracciolo EA, Ofiti EO. Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewire. Am J Cardiol 1993;71:34D-40D.
43. Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol 1993;71:3D-9D.
44. Kern MJ, Aguirre FU, Donohue TJ, et al. Continuous coronary flow velocity monitoring during coronary interventions: Velocity trend patterns associated with adverse events. Am Heart J 1994;128:426-434.
45. Tennet R, Wiggers CJ. The effect of coronary occlusion on myocardial contraction. Am J Physiol 1935;112:351-361.
46. Saran RK, Been M, Furniss SS, Hawkins T, Reid DS. Reduction in ST-segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function. Br Heart J 1990;64:113-117.
47. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. Assessment of coronary artery patency after thrombolytic therapy: Accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18: 44-49.
48. von Essen R, Schmidt W, Uebis R et al. Myocardial infarction and thrombolysis: Electrocardiographic short term and long term results using precordial mapping. Br Heart J 1985;54:6-10.
49. Krucoff MW, Groll MA, Pope JE, et al. for the TAMI 7 Study Group. Continuous 2-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a non-invasive method for real-time detection of failed reperfusion. Circulation 1993;88:437-446.
50. Dellborg M, Topol EJ, Swedburg K. Dynamic QRS complex and ST segment vectorcardiographic monitoring can identify vessel patency in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J 1991;122:943-948.
51. Kwon K, Freedman B, Wilcox I, et al. The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion. Am J Cardiol 1991;67:109-115.
52. Shah PK, Cercek B, Lew AS. Angiographic validation of bedside markers of reperfusion. J Coll Cardiol 1993; 21:55-61.
53. Kircher BJ, Topol EJ, O'Neill WW, Pitt B. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Cardiol 1987;59:513-515.
54. Garabedian HD, Gold HK, Yasuda T, et al. Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: Correlation with acute angiography. J Am Coll Cardiol 1988;11:729-734.
55. Abendschein DR, Ellis AK, Eisenberg PR, Klocke FJ, Sobel BE, Jaffe AS. Prompt detection of coronary recanulization by analysis of rates of change of concentrations of macromolecular markers in plasma. Cor Art Dis 1991;2: 201-212.
56. Puleo PR, Perryman MB. Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms. J Am Coll Cardiol 1991; 17:1047-1052.
57. Abe J, Yamaguchi T, Isshiki T, et al. Myocardial reperfusion can be predicted by myoglobin/creatine kinase ratio of a single blood sample obtained at the time of admission. Am Heart J 1993;126:279-285.
58. Abe S, Arima S, Yamashita T, et al. Early assessment of reperfusion therapy using cardiac troponin T. J Am Coll Cardiol 1994;23:1382-1389.
59. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991;83:902-912.
60. Decoster PM, Melin JA, Detry JMR, et al. Coronary artery reperfusion in acute myocardial infarction: Assessment by pre- and post-intervention thallium-201 myocardial perfusion imaging. Am J Cardiol 1985;55:889-895.
61. Jain D, Wackers FJ, Zaret BL. Radionuclide Imaging Techniques in the Thrombolytic Era. Boston: Kluwer Academic Publishers, 1994:195-217.
62. Heller LI, Villegas B, Weiner BM, McSherry BA, Dahlberg ST, Leppo JA. Sequential teburoxime imaging during and after balloon occlusion of a coronary artery. J Am Coll Cardiol 1993;1:1319-1327.
63. Siu SC, Weyman AE. Left Ventricle III: Coronary Artery Disease - Clinical Manifestations and Complications. Philadelphia: Lea & Febiger, 1994:656-686.
64. Oh JK, Gersh BJ, Nassef LA, et al. Effects of acute reperfusion on regional myorardial function: Serial two-dimensional echocardiography assessment. Int J Cardiol 1989;22:161-168.
65. Bourdillon PDV, Broderick TM, Williams ES, et al. Early recovery of regional left ventricular function after reperfusion in acute myocardial infarction assessed by 2-dimensional echocardiography. Am J Cardiol 1989;63: 641-646.
66. Masuyama T, Kudama K, Lee JM, Nanto S, Kitabatake A, Kamada T. Effects of coronary angioplasty on left ventricular diastolic filling in patients with old myocardial infarction: A study of pulsed Doppler echocardiography. Eur Heart J 1991;12:34-38.
67. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-1705.
68. Feinstein SB, Lang RM, Dick C, et al. Contrast echocardiography during coronary arteriography in humans: Perfusion and anatomic studies. J Am Coll Cardiol 1988;11: 59-65.
69. Voci P, Bilotta F, Merialdo P, Eng C, Agati TJ. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: A transesophageal echocardiography dipyridamole study. J Am Soc Echocardiogr 1994; 7:337-346.
70. Saeed M, Wendland MF, Yu KK, et al. Identification of myocardial reperfusion with echo planar magnetic resonance imaging. Discrimination between occlusive and reperfused infarctions. Circulation 1994;90:1492-1501.
71. Poncelot BP, Weisskoff RM, Wedeen VJ, Brady TJ, Kantor H. Time of flight quantification of coronary flow with echoplanar MRI. Magn Reson Med 1993;30:447-457.
72. Clarke GD, Eckels R, Chancy C, et al. Measurement of absolute eplcardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging. Circulation 1995;91:2627-2634.
73. Carney RJ, Murphy GA, Brandt TR, et al. for the RAAMI Study Investigators. Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. J Am Coll Cardiol 1992;20:17-23.
74. Anderaon JL, Sorensen SG, Morcno FL, et al. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators. Circulation 1991;83:126-140.
75. Ishihara M, Sato H, Tateishi H, Kawagoe T, Muraoka Y, Yoshimura M. Comparison of thrombolysis in myocardial infarction perfusion grades 2 and 3 after anterior wall infarction. Am J Cardiol 1993;71:428-430.
76. Lincoff AM, Ellis SG, Galeana A, et al. for the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Is a coronary artery with TIMI grade 2 flow "patent?" Outcome in the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trial (abstr). Circulation 1992;86(Suppl I):I268.